Ubiquigent news - the latest biotech news from Labiotech.eu

How to get started in life sciences – tips from six top women biotech leaders

Jim Cornall — Wed, 08 Mar 2023 08:58:45 +0000

The life sciences industry might seem like an attractive sector for women to start their career find a job. But just how should women get started in the sector? We asked six top professionals in the field for their advice. We asked Charli Batley, COO, Phoremost; Tamsin Mansley, president, Optibrium Inc. and global head of […]

The post How to get started in life sciences – tips from six top women biotech leaders appeared first on Labiotech.eu.

© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Women in STEM: challenges and opportunities

Jim Cornall — Wed, 08 Mar 2023 08:36:00 +0000

In this article to celebrate International Women’s Day, we asked women in STEM for their comments on the challenges they have faced in their careers so far, and how solutions can emerge from these challenges. We get advice from Fiona McLaughlin, CSO, Avacta Therapeutics; Maureen Coleman, chairman, CN Bio; Debora Lucarelli, CEO, Enhanc3D Genomics; Tamsin […]

The post Women in STEM: challenges and opportunities appeared first on Labiotech.eu.

How to encourage more women in life science jobs

Jim Cornall — Wed, 08 Mar 2023 08:22:00 +0000

In this article to celebrate International Women’s Day, we asked six women biotech professionals for their observations on women in the life sciences industry. We spoke to Sheelagh Frame, CSO, Ubiquigent; Debora Lucarelli, CEO, Enhanc3D Genomics; Charli Batley, COO, Phoremost; Tamsin Mansley, president, Optibrium Inc. and global head of application science, Optibrium; Maureen Coleman, chairman, […]

The post How to encourage more women in life science jobs appeared first on Labiotech.eu.

Ubiquigent and University of Glasgow to collaborate on drug discovery

Jim Cornall — Tue, 24 Jan 2023 09:22:45 +0000

Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, is supporting a Master’s student at the University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neruodegenerative, renal, and cardiovascular diseases. Overseen by structural biology experts […]

The post Ubiquigent and University of Glasgow to collaborate on drug discovery appeared first on Labiotech.eu.

We DUB this target ‘druggable’

External Contributor — Wed, 11 Jan 2023 08:16:03 +0000

By Sheelagh Frame, CSO at Ubiquigent Modulation of the ubiquitin-proteasome system (UPS) presents a rich source for drug discovery. Recent years have seen the clinical validation of proteolysis-targeting chimeras (PROTACs) unlock the ability to drug the undruggable, by exploiting E3 ligases to mediate targeted protein degradation (TPD), paving the way to tackle exciting new drug […]

The post We DUB this target ‘druggable’ appeared first on Labiotech.eu.

Drug discovery company signs exclusive license to use university’s technology

Liza Laws — Mon, 31 Oct 2022 17:00:01 +0000

A drug discovery and development company using deubiquitylase (DUB) modulators as therapeutics for areas of high unmet needs has signed an exclusive license with the University of Southern Denmark for its UbiSite technology. Sheelagh Frame, is chief scientific officer, at Ubiquigent, the company that has signed the agreement. She said: “We are delighted to have […]

The post Drug discovery company signs exclusive license to use university’s technology appeared first on Labiotech.eu.